AHCO vs. RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, VCYT, ADUS, and LFST
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), Addus HomeCare (ADUS), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.
AdaptHealth vs. Its Competitors
RadNet (NASDAQ:RDNT) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.
In the previous week, AdaptHealth had 1 more articles in the media than RadNet. MarketBeat recorded 7 mentions for AdaptHealth and 6 mentions for RadNet. RadNet's average media sentiment score of 0.92 beat AdaptHealth's score of 0.59 indicating that RadNet is being referred to more favorably in the media.
AdaptHealth has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
RadNet currently has a consensus price target of $69.60, indicating a potential upside of 23.93%. AdaptHealth has a consensus price target of $13.40, indicating a potential upside of 49.20%. Given AdaptHealth's higher possible upside, analysts clearly believe AdaptHealth is more favorable than RadNet.
AdaptHealth has a net margin of 2.63% compared to RadNet's net margin of -1.73%. AdaptHealth's return on equity of 6.96% beat RadNet's return on equity.
77.9% of RadNet shares are owned by institutional investors. Comparatively, 82.7% of AdaptHealth shares are owned by institutional investors. 5.6% of RadNet shares are owned by company insiders. Comparatively, 1.6% of AdaptHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500.
Summary
AdaptHealth beats RadNet on 11 of the 17 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
This page (NASDAQ:AHCO) was last updated on 7/4/2025 by MarketBeat.com Staff
